Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2020
PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary HypertensionMarie-Claude Lampron, Géraldine Vitry, Valérie Nadeau, et al.
The European Respiratory Journal|April 13, 2012
Plumbagin reverses proliferation and resistance to apoptosis in experimental PAHAudrey Courboulin, Marjorie Barrier, Tanya Perreault, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 1, 2018
FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertensionAlice Bourgeois, Caroline Lambert, Karima Habbout, et al.
Circulation|November 26, 2013
Role for DNA damage signaling in pulmonary arterial hypertensionJolyane Meloche, Aude Pflieger, Mylène Vaillancourt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2017
Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial HypertensionJolyane Meloche, Marie-Claude Lampron, Valérie Nadeau, et al.
Scientific Reports|July 5, 2017
HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial HypertensionOlivier Boucherat, Sophie Chabot, Roxane Paulin, et al.
International Journal of Molecular Sciences|April 3, 2021
Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial HypertensionYann Grobs, Charifa Awada, Sarah-Eve Lemay, et al.
European Urology|October 5, 2015
Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase KinaseAdam Kinnaird, Peter Dromparis, Bruno Saleme, et al.
JACC. Basic to Translational Science|May 11, 2022
PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial HypertensionTsukasa Shimauchi, Olivier Boucherat, Tetsuro Yokokawa, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2019
Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial HypertensionAlice Bourgeois, Sébastien Bonnet, Sandra Breuils-Bonnet, et al.
Pageof 5